Aileron Therapeutics Inc (ALRN)
3.20
-0.01
(-0.31%)
USD |
NASDAQ |
May 31, 16:00
3.21
+0.01
(+0.31%)
After-Hours: 20:00
Aileron Therapeutics Cash from Financing (Quarterly)
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 15.79M |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.001M |
| September 30, 2021 | 0.026M |
| June 30, 2021 | 0.026M |
| March 31, 2021 | 55.60M |
| December 31, 2020 | 4.242M |
| September 30, 2020 | 0.298M |
| June 30, 2020 | 11.26M |
| March 31, 2020 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2019 | -0.015M |
| September 30, 2019 | -0.051M |
| June 30, 2019 | 23.86M |
| March 31, 2019 | 0.165M |
| December 31, 2018 | 1.277M |
| September 30, 2018 | 1.21M |
| June 30, 2018 | 0.012M |
| March 31, 2018 | 0.016M |
| December 31, 2017 | -0.244M |
| September 30, 2017 | 50.70M |
| June 30, 2017 | -0.436M |
| March 31, 2017 | 0.569M |
| December 31, 2016 | 18.96M |
| September 30, 2016 | 0.008M |
| June 30, 2016 | -0.065M |
| March 31, 2016 | 13.08M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.051M
Minimum
Sep 2019
55.60M
Maximum
Mar 2021
6.169M
Average
0.0005M
Median
Cash from Financing (Quarterly) Benchmarks
| EyePoint Pharmaceuticals Inc | 0.115M |
| INVO Bioscience Inc | 0.5274M |
| Bio-Path Holdings Inc | 0.174M |
| SINTX Technologies Inc | 5.328M |
| Sensus Healthcare Inc | 0.00 |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -5.271M |
| Free Cash Flow | -20.42M |
| Free Cash Flow Per Share (Quarterly) | -0.6349 |
| Free Cash Flow Yield | -115.2% |